Ruili Wang

机构：China Medical University · ORCID：0000-0003-3217-7890

发表论文 67 篇 · 总被引 1089 次 · h-index 14

代表论文

Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals (2025 · Journal of Hematology & Oncology · 被引 245)
Towards the Objective Speech Assessment of Smoking Status based on Voice Features: A Review of the Literature (2021 · Journal of Voice · 被引 23)
Construction of reduction-sensitive heterodimer prodrugs of doxorubicin and dihydroartemisinin self-assembled nanoparticles with antitumor activity (2022 · Colloids and Surfaces B Biointerfaces · 被引 16)
Murine pharmacokinetics and antimalarial pharmacodynamics of dihydroartemisinin trimer self-assembled nanoparticles (2021 · Parasitology Research · 被引 13)
A modified CEUS risk stratification model for adnexal masses with solid components: prospective multicenter study and risk adjustment (2024 · European Radiology · 被引 12)
Docetaxel prodrug and hematoporphyrin co-assembled nanoparticles for anti-tumor combination of chemotherapy and photodynamic therapy (2022 · Drug Delivery · 被引 9)